| Abcuro | US | series-b+ | $300.0M |
| AIVOCODE, INC. | US | unknown | $2.6M |
| ALCAMENA STEM CELL THERAPEUTICS, LLC | US | unknown | $1.5M |
| Alloy Therapeutics, Inc. | US | unknown | $30.0M |
| AminoChain | US | seed | $7.0M |
| Amplifi Vascular, Inc. | US | unknown | $5.9M |
| Anagram Therapeutics | US | series-b+ | $250.0M |
| Anagram Therapeutics | US | series-b+ | $285.0M |
| Apmonia Therapeutics | FR | unknown | $7.6M |
| AptaTargets | ES | unknown | $7.0M |
| Asgard Therapeutics | SE | unknown | $2.7M |
| Atamyo Therapeutics | FR | unknown | $2.7M |
| AXOFT, INC. | US | unknown | $34.2M |
| Betaglue Technologies | IT | unknown | $33.6M |
| Bio-Sourcing | BE | unknown | $2.7M |
| Biomakers, Inc. | US | unknown | $5.9M |
| Boost Pharma | SE | series-a | $10.8M |
| BrainEver | FR | series-b+ | $38.8M |
| Canal Biosciences, Inc. | US | unknown | $2.3M |
| Captor Therapeutics | PL | unknown | $38.0M |
| Cellbricks Therapeutics | DE | seed | $10.8M |
| Cellevate | SE | seed | $7.1M |
| Cellply | IT | series-b+ | $7.7M |
| CHARM Therapeutics | GB | series-b+ | $150.0M |
| Cherry Biotech | FR | unknown | $2.7M |
| Clepio Biotech | IT | unknown | $2.7M |
| Clover Biopharmaceuticals, Ltd. | US | unknown | $3.6M |
| Connecta Therapeutics | ES | unknown | $5.9M |
| Connecta Therapeutics | ES | unknown | $2.7M |
| Dalan Bio | ES | seed | $3.0M |
| Diamante | IT | unknown | $2.7M |
| EMUNO Therapeutics | DE | unknown | $2.7M |
| Erg Bio | US | seed | $6.5M |
| ErVaccine Technologies | FR | seed | $4.8M |
| ErVimmune | FR | unknown | $21.6M |
| Exactmer | GB | unknown | $2.7M |
| Fastbase Solutions | ES | unknown | $2.7M |
| FluIDect | DE | seed | $2.7M |
| Galecto | DK | unknown | $281.9M |
| Gate2Brain | ES | unknown | $7.6M |
| Gedea Biotech | SE | unknown | $6.2M |
| Genera Istrazivanja | HR | unknown | $2.7M |
| Genera Research | HR | unknown | $2.7M |
| Genesis New Ventures, LLC | US | unknown | $4.2M |
| GreenMark Biomedical Inc. | US | unknown | $5.0M |
| Hephaistos-Pharma | FR | unknown | $2.7M |
| hephaistos.bio | CH | unknown | $173,880 |
| Holloid | AT | unknown | $2.7M |
| IMAGINOSTICS, INC. | US | unknown | $5.4M |
| Inflammasome Therapeutics, Inc. | US | unknown | $13.2M |
| Integra Therapeutics | ES | unknown | $2.7M |
| Invitris | DE | unknown | $2.7M |
| Kardigan | US | series-b+ | $554.0M |
| Kyron Bio | FR | unknown | $6.5M |
| Level Nine | DE | seed | $1.1M |
| Leyden Laboratories | NL | unknown | $2.7M |
| Linnaeus Therapeutics, Inc. | US | unknown | $5.0M |
| Loyal | US | series-b+ | $250.0M |
| Meta-Flux | IE | seed | $2.0M |
| MiNDERA Corp | US | unknown | $25.4M |
| Mitera Biosciences Inc. | US | unknown | $1.1M |
| Mussel Polymers, Inc. | US | unknown | $4.8M |
| Myopax | DE | unknown | $2.7M |
| O11 Biomedical | DE | unknown | $2.7M |
| Ochre Bio | GB | series-b+ | $75.0M |
| Outlook Therapeutics, Inc. | US | unknown | $5.0M |
| Ovala, Inc. | US | unknown | $3.3M |
| Oxolife | ES | unknown | $2.7M |
| Pacegenix, Inc. | US | unknown | $22.5M |
| Pearl Diagnostics, Inc. | US | unknown | $11.2M |
| Peptinov | FR | unknown | $2.7M |
| Peptomyc | ES | unknown | $2.7M |
| PharmNovo | SE | unknown | $2.7M |
| PraxisPro | US | seed | $6.0M |
| Primogene | DE | seed | $4.4M |
| Resolute Science, Inc. | US | unknown | $2.9M |
| Resother Pharma | DK | unknown | $2.7M |
| Rest Therapeutics | FR | unknown | $5.0M |
| Resurrect Bio | GB | series-a | $9.5M |
| RNhale | DE | unknown | $2.7M |
| Scope Biosciences | NL | unknown | $2.7M |
| Sea4Us | PT | unknown | $2.7M |
| Silk Biomaterials | IT | unknown | $2.7M |
| Simergent, LLC | US | unknown | $8.8M |
| StablePharma | GB | unknown | $2.7M |
| Step Pharma | FR | unknown | $102.5M |
| Synboli | FR | series-a | $4.1M |
| Sync Biosystems | NL | unknown | $2.7M |
| Tafalgie Therapeutics | FR | unknown | $2.7M |
| Targtex | PT | unknown | $2.7M |
| TECregen | CH | seed | $12.0M |
| Tetrakit Technologies | DK | unknown | $2.7M |
| Tilt Biotherapeutics | FI | unknown | $2.7M |
| Topos Bio | US | seed | $10.5M |
| TreeFrog Therapeutics | FR | unknown | $82.0M |
| Trince | BE | unknown | $2.7M |
| Tubulis | DE | series-b+ | $361.8M |
| UniverCell | DE | unknown | $10.1M |
| Valinor | US | seed | $13.0M |
| VarmX | NL | unknown | $2.7M |